Oncolytics Biotech (ONCY) Return on Capital Employed (QoQ) (2011 - 2025)
Oncolytics Biotech (ONCY) Return on Capital Employed (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Oncolytics Biotech | 101.16 Mn | 101.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -15,196.00 |
| Dec 31, 2024 | -10,957.00 |
| Sep 30, 2024 | -10,417.00 |
| Dec 31, 2023 | 1,475.00 |
| Sep 30, 2023 | -2,848.00 |
| Jun 30, 2023 | -1,856.00 |
| Mar 31, 2023 | -675.00 |
| Dec 31, 2022 | 1,029.00 |
| Sep 30, 2022 | -3,684.00 |
| Jun 30, 2022 | -3,623.00 |
| Mar 31, 2022 | 2,335.00 |
| Dec 31, 2021 | -16,056.00 |
| Sep 30, 2021 | 2,216.00 |
| Jun 30, 2021 | 1,760.00 |
| Mar 31, 2021 | -1,443.00 |
| Dec 31, 2020 | 11,544.00 |
| Sep 30, 2020 | -278.00 |
| Sep 30, 2019 | -5,801.00 |
| Jun 30, 2019 | -9,689.00 |
| Mar 31, 2019 | -5,614.00 |